Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
CPC-201 · 2 trials · 2 indications
To evaluate the safety labs and adverse events from baseline, during the study and at the end of the study.
Number of participants who reached Donepezil Maximum Tolerated Dose of 40 mg/day (highest allowed per protocol) at the end of donepezil dose titration phase and at the end of the maintenance phase.
| Arm | Type | Description |
|---|---|---|
| CPC-201 | EXPERIMENTAL | - |
| Name | Type | Description |
|---|---|---|
| CPC-201 | DRUG | - |
Inclusion Criteria: 1. Have signed an Institutional Review Board (IRB) approved informed consent document indicating that they understand the purpose of and procedures required by the study and are willing to participate in the study and comply with all study procedures and restrictions. Informed c...
Top 20 of 24 competitors